$SN

Shah Neil B. sold $3.8M of SN

Shah Neil B. (Chief Commercial Officer) sold 20,333 shares of SharkNinja, Inc. (SN) at an average of $184.69 ($184.58–$186.12, $3.76M total) across 3 trades on 2026-08-10.

Original reporting
SEC EDGAR · Shah Neil B.
Published Aug 11, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SN
Neutral
medium confidence
Mentioned
$SN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNNeutralLow
01

Why it matters

A $3.76M open-market sale by a senior officer is typically a sentiment datapoint rather than a fundamental catalyst, absent any linked corporate event.

02

Market read

Traders may monitor SN for follow-on insider activity, but this specific disclosure alone is unlikely to drive a major repricing.

03

What to watch

The filing does not state a 10b5-1 plan and provides only sale details, not reasons; without context (e.g., prior sales cadence), interpretation is limited.

Relevance 6/10Novelty 4/10Timing: filed 2026-08-11 after-hours; transaction dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for SharkNinja, Inc. (SN) by Chief Commercial Officer Shah Neil B.

Company-level read

Ticker impact

$SNNeutralMedium confidence
Context

SharkNinja (SN) disclosed an insider open-market sale by CCO Shah Neil B. totaling about $3.76M across 20,333 shares on 2026-08-10.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any reaction is likely limited to short-term sentiment.

Evidence & confidence

Form 4 insider sales are common and the article provides no accompanying guidance, legal/regulatory event, or operational change. The transaction is explicitly an open-market sale with no 10b5-1 plan stated.

Market effects

No direct sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be weaker than traders assume.

Key entities

  • SharkNinja, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Shah Neil B.

    Chief Commercial Officer who sold 20,333 shares in open-market trades on 2026-08-10.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNHighAI 8/10

Smith & Nephew merger talks with J&J orthopaedics unit collapse over CEO role, FT reports

Smith & Nephew's merger talks with Johnson & Johnson's orthopaedics unit collapsed over disagreement on the CEO role, according to the Financial Times. The deal would have valued the unit at up to $22 billion, nearly double Smith & Nephew's market cap. Both companies were aligned on financial terms but disagreed on leadership. Smith & Nephew's former CEO left in 2019 over pay demands.

$SNMed

UBS sees attractive risk/reward in three European medtech into Q3 results

UBS identifies Convatec, Smith & Nephew, and Sonova as attractive European medtech stocks ahead of Q3 results, citing revenue and earnings growth expectations. Convatec is expected to report 6% organic growth, Smith & Nephew may undergo a strategic review, and Sonova could raise guidance due to market growth and currency tailwinds. UBS provides price targets for each company.

$SNHighAI 8/10

Blowout Guidance Sends SharkNinja Shares Higher

SharkNinja (SN) reported Q2 2026 net sales of $1.77B (up 22.2% YoY) and adjusted net income of $178M (up 29%). The company raised full-year 2026 guidance, targeting up to 17% sales growth and $6.55 adjusted EPS. SN shares have risen 56% YTD, supported by institutional demand and strong fundamentals, including 3-year sales growth of 20% and EPS growth of 63.8%.

$SNMed

UBS raises SharkNinja stock price target to $219 on product expansion

UBS raised its price target for SharkNinja (NYSE:SN) to $219.10 from $147 and kept a Buy rating, citing Q2 results and faster product launches. The firm pointed to 13 new products year to date versus nine in the first eight months of 2025, plus plans for up to three new subcategories in 2026. SN trades at $187.68 and reported revenue of $1.77B (+22.2%) with adjusted EPS of $0.92.